Augustine Therapeutics announces first patient dosed in Phase I for the treatment of Charcot-Marie-Tooth disease

Home 9 Uncategorized 9 Augustine Therapeutics announces first patient dosed in Phase I for the treatment of Charcot-Marie-Tooth disease